INIFY Laboratories AB's quarterly market cap
increased
from Jun. 2024 (kr325.70 Mil) to Sep. 2024 (kr348.32 Mil) but then
declined
from Sep. 2024 (kr348.32 Mil) to Dec. 2024 (kr226.19 Mil).
INIFY Laboratories AB's annual market cap
increased
from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr560.93 Mil) but then
declined
from Dec. 2023 (kr560.93 Mil) to Dec. 2024 (kr226.19 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. INIFY Laboratories AB's Enterprise Value for Today is kr503.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of INIFY Laboratories AB's Market Cap
For the Diagnostics & Research subindustry, INIFY Laboratories AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INIFY Laboratories AB's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, INIFY Laboratories AB's Market Cap distribution charts can be found below:
* The bar in red indicates where INIFY Laboratories AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
INIFY Laboratories AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INIFY Laboratories AB (OSL:INIFY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
INIFY Laboratories AB Market Cap Related Terms
Thank you for viewing the detailed overview of INIFY Laboratories AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
INIFY Laboratories AB provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized, and AI-supported workflow to optimize quality and response times, initially within the prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer's organization.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSL:INIFY has been successfully added to your 